Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFCD-1004: Pharmacogenetics of Gemcitabine in Pancreatic Cancer
NCT01416662Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jun 2011
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in pancreatic adenocarcinoma (PDAC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Jun 2011; status: completed.
02
Drugs
gemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01416662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01416662.